Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
about
Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virusAntiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantationAntiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantationAntiviral therapy for recurrent liver graft infection with hepatitis C virusTreatment strategies for chronic hepatitis C prior to and following liver transplantationHepatitis C and liver transplantationHepatitis C screeningA 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patientsDonor factors predicting recipient survival after liver retransplantation: the retransplant donor risk index.No improvement in long-term liver transplant graft survival in the last decade: an analysis of the UNOS data.Feasibility and safety of percutaneous coronary intervention in patients with end-stage liver disease referred for liver transplantation.Recurrent hepatitis C after liver transplantation: clinical and therapeutical issues.Recurrent hepatitis C after liver transplantation.Management of recurrent hepatitis C after liver transplantation.Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection.Impact of immunosuppressive therapy on recurrence of hepatitis C.Retransplantation for recurrent hepatitis C.Role of living donor liver transplantation in the treatment of hepatitis C virus infectionCurrent therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C.Mycophenolate mofetil in patients with hepatitis C virus infection.Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop.Risk factors for hepatitis C recurrence after liver transplantation.Hepatitis C Is Poorly Associated With Drug Use in Cambodian Americans in Lowell, Massachusetts.Methadone maintenance therapy in liver transplantation.Biliary tract reconstruction with or without T-tube in orthotopic liver transplantation: a systematic review and meta-analysis.The role of autonomic dysfunction in predicting 1-year mortality after liver transplantation.Limited Fibrosis Progression but Significant Mortality in Patients Ineligible for Interferon-Based Hepatitis C TherapyOutcome after liver re-transplantation in patients with recurrent chronic hepatitis C.PEGYLATED INTERFERON AND RIBAVIRIN FOR TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION: a single-liver transplant center experience in Brazil.Sofosbuvir plus simeprevir treatment of recurrent genotype 1 hepatitis C after liver transplant.Impact of comorbidity on waiting list and post-transplant outcomes in patients undergoing liver retransplantation.Predictors of survival after In vivo split liver transplantation: analysis of 110 consecutive patients.Recent advances and controversies in surgical management of liver diseases: summary of liver sessions of 7th World Congress of IHPBA 2006.HCV in liver transplantation.Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent hepatitis C.Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection.Indications for liver transplantation in patients with chronic hepatitis B and C virus infection and hepatocellular carcinoma.A cost-effectiveness analysis of biliary anastomosis with or without T-tube after orthotopic liver transplantation.Is it cost-effective to treat recurrent hepatitis C infection in orthotopic liver transplantation patients?Hepatocellular carcinoma complicating recurrent hepatitis C after liver transplantation.
P2860
Q24201973-D6C060BE-9914-44C7-842F-257DF34E4705Q24202008-A452DF53-4C7C-43EF-8D79-A2F2C86D9FB8Q24235577-02A016D0-7843-4D94-A356-8BA37FDD85CEQ24240405-270685B1-7529-425C-A06F-1003B6C939A9Q26771244-BF4E04C5-FE36-49E9-89E0-5E20E78DFE4AQ27490388-6DFC90A6-4AC1-4495-A106-DC3745F994F0Q28083429-7B927D5A-2FFD-46C8-A628-FE139CAC5CC7Q28346817-5E642270-2A2F-486E-85A0-E3D9EF01E434Q30444010-AFF14CE0-35AF-4158-B693-C81E0CD972DBQ31039949-CC560CB0-3503-4C96-AA64-9770DC7F6A22Q33394599-09143134-25BC-4065-8C63-1FA7B2BA288FQ33888820-88B4B608-D5AC-4B89-B482-F8470066D441Q33969819-A2BF5C9B-0778-4281-9F5E-6BCDCFFB8535Q34266517-9D79D341-F10A-426B-A51D-D5FD9F31426EQ34294938-2A03616E-825A-4F84-BE68-455D156851BFQ34936148-88E765DD-0B56-4EB6-B16C-5D1FF2CDFEABQ34936182-69DDA97F-94EF-44F8-8951-142BC82B3C22Q35540281-14E037A1-DA48-437E-8632-B2D153F34494Q35588125-4C616FB0-F190-4868-B274-539BDECD6A83Q36085885-1FC34017-38D3-474F-8CC3-F4A2880B26A4Q36655931-56B04D6A-7846-4020-A655-D10B069E6AFDQ36980754-BB22BDC7-C9A5-4A34-BBB9-4170F3A007D6Q37091589-902ACA59-B804-496E-8366-C51B379E2199Q37798539-2EDD2BF8-CE89-4DE3-82F0-7D9634418EE0Q38316185-244AF4DF-8F3C-4B01-B95E-2CB57E3F7FBFQ39009623-706D35DF-C23D-44A2-9DFD-5184BD3266B9Q39521793-8BC3EF9C-D812-4064-8363-5881CA0DE131Q40196672-4A691A93-E7C4-4FEE-900B-CB5395ED5782Q40943341-1992B290-5D59-4717-9328-7FEB09DF281EQ41006072-CBF18DDD-0578-4703-BB7F-0EA3D1D81F1EQ41169640-7707C82B-000C-4767-A256-D9D7275BD95DQ41759588-08031D3B-6BC4-48D5-8CE9-40C56EA3F602Q42572041-EFFBA20C-5F46-4E3E-A9B3-F7B2C23C602EQ42982631-2115D4A8-045C-4660-AC03-4EA2453F031DQ43049477-BA06250B-96D5-4601-8CFE-C03F549C845FQ44211421-91AE6898-06B6-44BF-8AB2-9443536C0516Q44243304-131BEE26-21B8-4C48-94C9-06FB79D33E6FQ45995102-8E01AD4B-1EC9-4EE9-8A77-6B2C10E545B9Q46085776-5B31B499-D927-4CFD-90EF-A8C9C929E0C7Q46221908-0E0DCED0-3E6B-4CD7-99C5-3DD44C116EA2
P2860
Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Orthotopic liver transplantati ...... year single-center experience.
@ast
Orthotopic liver transplantati ...... year single-center experience.
@en
type
label
Orthotopic liver transplantati ...... year single-center experience.
@ast
Orthotopic liver transplantati ...... year single-center experience.
@en
prefLabel
Orthotopic liver transplantati ...... year single-center experience.
@ast
Orthotopic liver transplantati ...... year single-center experience.
@en
P2093
P2860
P1433
P1476
Orthotopic liver transplantati ...... year single-center experience.
@en
P2093
A Baquerizo
D G Farmer
J F Markmann
K E Drazan
L I Goldstein
P2860
P304
824-31; discussion 831-3
P356
10.1097/00000658-199906000-00009
P407
P577
1999-06-01T00:00:00Z